Pre-eclampsia and Cardiovascular Disease Risk Assessment in Women

American Journal of Perinatology

Volumn 33, Issue 8, 2016, Pages 723-731

  Murphy, Malia S Q ^a   Smith, Graeme N ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

cardiovascular disease; pre eclampsia; pregnancy; women

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FAMILY HISTORY; HEART INFARCTION; HUMAN; LIFESTYLE; MATERNAL HYPERTENSION; MATERNAL OBESITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SMOKING; FEMALE; PREGNANCY COMPLICATION; RISK ASSESSMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES, GESTATIONAL; FEMALE; HUMANS; LIFE STYLE; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 84962685624     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0036-1572536     Document Type: Review

References (98)

1. Mosca L.; Benjamin E. J.; Berra K.; et al. American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol: 2011; 57 12 1404 1423
2. Long T.; Taubenheim A.; Wayman J.; Temple S.; Ruoff B. The Heart Truth: Using the Power of Branding and Social Marketing to Increase Awareness of Heart Disease in Women. Soc Mar Q: 2008; 14 3 3 29
3. Lee D. S.; Chiu M.; Manuel D. G.; et al. Canadian Cardiovascular Outcomes Research Team. Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors. CMAJ: 2009; 181 3-4 E55 E66
4. Spaan J.; Peeters L.; Spaanderman M.; Brown M. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension: 2012; 60 6 1368 1373
5. Heidenreich P. A.; Trogdon J. G.; Khavjou O. A.; et al. American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation: 2011; 123 8 933 944
6. Mosca L.; Manson J. E.; Sutherland S. E.; Langer R. D.; Manolio T.; Barrett-Connor E.; Writing Group. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation: 1997; 96 7 2468 2482
7. Mosca L.; Grundy S. M.; Judelson D.; et al. Guide to Preventive Cardiology for Women. AHA/ACC Scientific Statement Consensus panel statement. Circulation: 1999; 99 18 2480 2484
8. Canto J. G.; Shlipak M. G.; Rogers W. J.; et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA: 2000; 283 24 3223 3229
9. McSweeney J. C.; Cody M.; O'Sullivan P.; Elberson K.; Moser D. K.; Garvin B. J. Women's early warning symptoms of acute myocardial infarction. Circulation: 2003; 108 21 2619 2623
10. Giralt D.; Domingues-Montanari S.; Mendioroz M.; et al. The gender gap in stroke: a meta-analysis. Acta Neurol Scand: 2012; 125 2 83 90
11. Ryan C. J.; DeVon H. A.; Zerwic J. J. Typical and atypical symptoms: diagnosing acute coronary syndromes accurately. Am J Nurs: 2005; 105 2 34 36
12. Chandra N. C.; Ziegelstein R. C.; Rogers W. J.; et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med: 1998; 158 9 981 988
13. McLaughlin T. J.; Soumerai S. B.; Willison D. J.; et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med: 1996; 156 7 799 805
14. Yusuf S.; Hawken S.; Ounpuu S.; et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet: 2004; 364 9438 937 952
15. Unger T.; Chung O.; Csikos T.; et al. Angiotensin receptors. J Hypertens Suppl: 1996; 14 5 S95 S103
16. Malek A. M.; Alper S. L.; Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA: 1999; 282 21 2035 2042
17. Stokes J. III, Kannel W. B.; Wolf P. A.; D'Agostino R. B.; Cupples L. A. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up. Hypertension: 1989; 13 (5, Suppl): I13 I18
18. Vasan R. S.; Larson M. G.; Leip E. P.; et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med: 2001; 345 18 1291 1297
19. Lewington S.; Clarke R.; Qizilbash N.; Peto R.; Collins R.; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet: 2002; 360 9349 1903 1913
20. Wilkins K.; Campbell N. R.; Joffres M. R.; et al. Blood pressure in Canadian adults. Health Rep: 2010; 21 1 37 46
21. Oda E.; Abe M.; Kato K.; Watanabe K.; Veeraveedu P. T.; Aizawa Y. Gender differences in correlations among cardiovascular risk factors. Gend Med: 2006; 3 3 196 205
22. Shields M.; Carroll M. D.; Ogden C. L. Adult obesity prevalence in Canada and the United States. NCHS Data Brief: 2011; 56 1 8
23. Hubert H. B.; Feinleib M.; McNamara P. M.; Castelli W. P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation: 1983; 67 5 968 977
24. Kannel W. B.; Cupples L. A.; Ramaswami R.; Stokes J. III, Kreger B. E.; Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol: 1991; 44 2 183 190
25. Li T. Y.; Rana J. S.; Manson J. E.; et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation: 2006; 113 4 499 506
26. Després J. P.; Lemieux I.; Bergeron J.; et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol: 2008; 28 6 1039 1049
27. Després J-P. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J Suppl: 2006; 8 (Supplement B): B4 B12
28. Must A.; Spadano J.; Coakley E. H.; Field A. E.; Colditz G.; Dietz W. H. The disease burden associated with overweight and obesity. JAMA: 1999; 282 16 1523 1529
29. Wilson P. W.; D'Agostino R. B.; Sullivan L.; Parise H.; Kannel W. B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med: 2002; 162 16 1867 1872
30. Park Y. W.; Zhu S.; Palaniappan L.; Heshka S.; Carnethon M. R.; Heymsfield S. B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med: 2003; 163 4 427 436
31. Legato M. J. Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy. Am J Cardiol: 2000; 86 (12A) 15L 18L
32. Kolovou G. D.; Anagnostopoulou K. K.; Damaskos D. S.; et al. Gender differences in the lipid profile of dyslipidemic subjects. Eur J Intern Med: 2009; 20 2 145 151
33. Manolio T. A.; Pearson T. A.; Wenger N. K.; Barrett-Connor E.; Payne G. H.; Harlan W. R. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol: 1992; 2 1-2 161 176
34. Walsh J. M.; Grady D. Treatment of hyperlipidemia in women. JAMA: 1995; 274 14 1152 1158
35. Mosca L.; Banka C. L.; Benjamin E. J.; et al. Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women's Association; Centers for Disease Control and Prevention; Office of Research on Women's Health; Association of Black Cardiologists; American College of Physicians; World Heart Federation; National Heart, Lung, and Blood Institute; American College of Nurse Practitioners. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation: 2007; 115 11 1481 1501
36. LaRosa J. C. Triglycerides and coronary risk in women and the elderly. Arch Intern Med: 1997; 157 9 961 968
37. Castelli W. P. The triglyceride issue: a view from Framingham. Am Heart J: 1986; 112 2 432 437
38. Kannel W. B.; McGee D. L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care: 1979; 2 2 120 126
39. Levit R. D.; Reynolds H. R.; Hochman J. S. Cardiovascular disease in young women: a population at risk. Cardiol Rev: 2011; 19 2 60 65
40. Giugliano D.; Marfella R.; Coppola L.; et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation: 1997; 95 7 1783 1790
41. Kawano H.; Motoyama T.; Hirashima O.; et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol: 1999; 34 1 146 154
42. Bowie A.; Owens D.; Collins P.; Johnson A.; Tomkin G. H. Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis: 1993; 102 1 63 67
43. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia: 1993; 36 11 1119 1125
44. Gress T. W.; Nieto F. J.; Shahar E.; Wofford M. R.; Brancati F. L. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med: 2000; 342 13 905 912
45. Roberts J. M.; Hubel C. A. The two stage model of preeclampsia: variations on the theme. Placenta: 2009; 30 Suppl A: S32 S37
46. Howard B. V.; Cowan L. D.; Go O.; Welty T. K.; Robbins D. C.; Lee E. T. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care: 1998; 21 8 1258 1265
47. Barrett-Connor E.; Wingard D. L. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol: 1983; 118 4 489 496
48. Garcia M. J.; McNamara P. M.; Gordon T.; Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes: 1974; 23 2 105 111
49. Goldberg R. J.; Larson M.; Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. Arch Intern Med: 1996; 156 5 505 509
50. Sowers J. R. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med: 1998; 158 6 617 621
51. Tanasescu M.; Cho E.; Manson J. E.; Hu F. B. Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr: 2004; 79 6 999 1005
52. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation: 2002; 106 25 3143 3421
53. Grundy S. M.; Cleeman J. I.; Daniels S. R.; et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation: 2005; 112 17 2735 2752
54. Ervin R. B. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Rep: 2009; 13 1 7
55. Riediger N. D.; Clara I. Prevalence of metabolic syndrome in the Canadian adult population. CMAJ: 2011; 183 15 E1127 E1134
56. Dunn N. R.; Faragher B.; Thorogood M.; et al. Risk of myocardial infarction in young female smokers. Heart: 1999; 82 5 581 583
57. Critchley J. A.; Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA: 2003; 290 1 86 97
58. Krauss R. M.; Eckel R. H.; Howard B.; et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation: 2000; 102 18 2284 2299
59. Stampfer M. J.; Hu F. B.; Manson J. E.; Rimm E. B.; Willett W. C. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med: 2000; 343 1 16 22
60. U.S. Department of Agriculture and U.S. Department of Health and Human Services Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office
61. Mora S.; Cook N.; Buring J. E.; Ridker P. M.; Lee I. M. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation: 2007; 116 19 2110 2118
62. Hu F. B.; Stampfer M. J.; Colditz G. A.; et al. Physical activity and risk of stroke in women. JAMA: 2000; 283 22 2961 2967
63. US Department of Health and Human Services Physical Activity Guidelines Advisory Committee final report. http://www.health.gov/PAGuidelines/Report/Default.aspx
64. Lloyd-Jones D. M.; Nam B. H.; D'Agostino R. B. Sr.; et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA: 2004; 291 18 2204 2211
65. Murabito J. M.; Pencina M. J.; Nam B. H.; et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA: 2005; 294 24 3117 3123
66. Reilly J. J.; Armstrong J.; Dorosty A. R.; et al. Avon Longitudinal Study of Parents and Children Study Team. Early life risk factors for obesity in childhood: cohort study. BMJ: 2005; 330 7504 1357
67. Gilman S. E.; Rende R.; Boergers J.; et al. Parental smoking and adolescent smoking initiation: an intergenerational perspective on tobacco control. Pediatrics: 2009; 123 2 e274 e281
68. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol: 2003; 15 6 465 471
69. Brosens I. A.; Robertson W. B.; Dixon H. G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu: 1972; 1 177 191
70. Meekins J. W.; Pijnenborg R.; Hanssens M.; McFadyen I. R.; van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol: 1994; 101 8 669 674
71. Sattar N.; Greer I. A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ: 2002; 325 7356 157 160
72. Mostello D.; Catlin T. K.; Roman L.; Holcomb W. L. Jr, Leet T. Preeclampsia in the parous woman: who is at risk? Am J Obstet Gynecol: 2002; 187 2 425 429
73. Bellamy L.; Casas J. P.; Hingorani A. D.; Williams D. J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ: 2007; 335 7627 974
74. Romundstad P. R.; Magnussen E. B.; Smith G. D.; Vatten L. J. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation: 2010; 122 6 579 584
75. Brown M. C.; Best K. E.; Pearce M. S.; Waugh J.; Robson S. C.; Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol: 2013; 28 1 1 19
76. Irgens H. U.; Reisaeter L.; Irgens L. M.; Lie R. T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ: 2001; 323 7323 1213 1217
77. Kestenbaum B.; Seliger S. L.; Easterling T. R.; et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis: 2003; 42 5 982 989
78. Wikström A. K.; Haglund B.; Olovsson M.; Lindeberg S. N. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG: 2005; 112 11 1486 1491
79. Sibai B. M.; el-Nazer A.; Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol: 1986; 155 5 1011 1016
80. Smith G. C.; Pell J. P.; Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet: 2001; 357 9273 2002 2006
81. Stepan H.; Nordmeyer A. K.; Faber R. Proteinuria in hypertensive pregnancy diseases is associated with a longer persistence of hypertension postpartum. J Hum Hypertens: 2006; 20 2 125 128
82. Suzuki H.; Watanabe Y.; Arima H.; Kobayashi K.; Ohno Y.; Kanno Y. Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol: 2008; 12 2 102 109
83. Berks D.; Steegers E. A.; Molas M.; Visser W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol: 2009; 114 6 1307 1314
84. McDonald S. D.; Malinowski A.; Zhou Q.; Yusuf S.; Devereaux P. J. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J: 2008; 156 5 918 930
85. Smith G. N.; Walker M. C.; Liu A.; et al. Pre-Eclampsia New Emerging Team (PE-NET). A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol: 2009; 200 1 58.e1 58.e8
86. Smith G. N.; Pudwell J.; Walker M.; Wen S. W. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can: 2012; 34 9 830 835
87. Smith G. N.; Pudwell J.; Walker M.; Wen S. W. Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can: 2012; 34 9 836 841
88. Manten G. T.; Sikkema M. J.; Voorbij H. A.; Visser G. H.; Bruinse H. W.; Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy: 2007; 26 1 39 50
89. van Rijn B. B.; Nijdam M. E.; Bruinse H. W.; et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol: 2013; 121 5 1040 1048
90. Wolf M.; Hubel C. A.; Lam C.; et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab: 2004; 89 12 6239 6243
91. Ray J. G.; Vermeulen M. J.; Schull M. J.; Redelmeier D. A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet: 2005; 366 9499 1797 1803
92. Mosca L.; Benjamin E. J.; Berra K.; et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation: 2011; 123 11 1243 1262
93. Hoedjes M.; Berks D.; Vogel I.; et al. Motivators and barriers to a healthy postpartum lifestyle in women at increased cardiovascular and metabolic risk: a focus-group study. Hypertens Pregnancy: 2012; 31 1 147 155
94. Brown M. C.; Bell R.; Collins C.; et al. Women's perception of future risk following pregnancies complicated by preeclampsia. Hypertens Pregnancy: 2013; 32 1 60 73
95. Hoedjes M.; Berks D.; Vogel I.; et al. Preferences for postpartum lifestyle counseling among women sharing an increased cardiovascular and metabolic risk: a focus group study. Hypertens Pregnancy: 2011; 30 1 83 92
96. Mosca L.; Mochari H.; Christian A.; et al. National study of women's awareness, preventive action, and barriers to cardiovascular health. Circulation: 2006; 113 4 525 534
97. Smith G. N.; Pudwell J.; Roddy M. The Maternal Health Clinic: a new window of opportunity for early heart disease risk screening and intervention for women with pregnancy complications. J Obstet Gynaecol Can: 2013; 35 9 831 839
98. Cusimano M. C.; Pudwell J.; Roddy M.; et al. The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications. Am J Obstet Gynecol: 2014; 210 5 438.e1 438.e9